Literature DB >> 24132962

Stroke prevention in older adults with atrial fibrillation.

Michiel Coppens, Robert G Hart, John W Eikelboom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24132962      PMCID： PMC3832552          DOI： 10.1503/cmaj.131291

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  9 in total

Review 1.  New oral anticoagulants in elderly patients.

Authors:  Stefano Barco; Yuk Wah Cheung; John W Eikelboom; Michiel Coppens
Journal:  Best Pract Res Clin Haematol       Date:  2013-07-21       Impact factor: 3.020

2.  Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.

Authors:  Robby Nieuwlaat; Alessandro Capucci; Gregory Y H Lip; S Bertil Olsson; Martin H Prins; Fred H Nieman; José López-Sendón; Panos E Vardas; Etienne Aliot; Massimo Santini; Harry J G M Crijns
Journal:  Eur Heart J       Date:  2006-05-26       Impact factor: 29.983

3.  2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

Authors:  A John Camm; Gregory Y H Lip; Raffaele De Caterina; Irene Savelieva; Dan Atar; Stefan H Hohnloser; Gerhard Hindricks; Paulus Kirchhof
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

4.  Dabigatran and postmarketing reports of bleeding.

Authors:  Mary Ross Southworth; Marsha E Reichman; Ellis F Unger
Journal:  N Engl J Med       Date:  2013-03-13       Impact factor: 91.245

5.  Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.

Authors:  Allan C Skanes; Jeff S Healey; John A Cairns; Paul Dorian; Anne M Gillis; M Sean McMurtry; L Brent Mitchell; Atul Verma; Stanley Nattel
Journal:  Can J Cardiol       Date:  2012 Mar-Apr       Impact factor: 5.223

6.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391

7.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.

Authors:  P A Wolf; R D Abbott; W B Kannel
Journal:  Stroke       Date:  1991-08       Impact factor: 7.914

8.  Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study.

Authors:  Torben Bjerregaard Larsen; Lars Hvilsted Rasmussen; Flemming Skjøth; Karen Margrete Due; Torbjörn Callréus; Mary Rosenzweig; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2013-04-03       Impact factor: 24.094

9.  Prescribing patterns of novel oral anticoagulants following regulatory approval for atrial fibrillation in Ontario, Canada: a population-based descriptive analysis.

Authors:  Yan Xu; Anne M Holbrook; Christopher S Simpson; Dar Dowlatshahi; Ana P Johnson
Journal:  CMAJ Open       Date:  2013-10-16
  9 in total
  2 in total

1.  Management of Haemarthrosis in Patients On Oral Anticoagulants.

Authors:  James Dalrymple; Andrew Davies; Alexandra Biggs; Shahil Rajcoomar; Ian Gill
Journal:  Geriatr Orthop Surg Rehabil       Date:  2022-05-11

Review 2.  Potential use of NOACs in developing countries: pros and cons.

Authors:  Durga Bista; Leanne Chalmers; Luke Bereznicki; Gregory Peterson
Journal:  Eur J Clin Pharmacol       Date:  2014-05-11       Impact factor: 2.953
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.